Literature DB >> 20236609

Transcriptional induction of minichromosome maintenance protein 7 (Mcm7) in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products.

Dong-Wook Kim1, Ji-Young Kim, Ju Hyun Moon, Kee-Beom Kim, Tong-Soo Kim, Sung-Jong Hong, Young Pil Cheon, Jhang Ho Pak, Sang-Beom Seo.   

Abstract

Clonorchiasis is an infection associated with bile duct malignancy and subsequent development of cholangiocarcinoma. This disease is mainly caused by Clonorchis sinensis worms and their excretory-secretory products (ESP). However, the precise molecular mechanisms of carcinogenesis remain to be determined. Previously, we established differential gene expression profiles from microarrays containing 23,920 human genes of known function in a human cholangiocarcinoma cell line, HuCCT1, treated with ESP. Among the upregulated genes, we focused on minichromosome maintenance protein 7 (Mcm7), which is implicated in various cancer types, and analyzed transcriptional regulation mediated by ESP to further elucidate its role in cholangiocarcinoma development. Global histone acetylation levels were increased in ESP-treated cells, along with histone acetyltransferase (HAT) protein expression. Detailed promoter analysis using reporter and chromatin immunoprecipitation assays revealed that transcriptional activation of Mcm7 is mediated by HAT recruitment to the promoter region upon C. sinensis ESP treatment. These findings contribute to clarification of the intrinsic mechanism underlying the cellular carcinogenesis process stimulated by Mcm7 in C. sinensis-treated host cells. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236609     DOI: 10.1016/j.molbiopara.2010.03.005

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  8 in total

1.  miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma.

Authors:  Nataliya Razumilava; Steve F Bronk; Rory L Smoot; Christian D Fingas; Nathan W Werneburg; Lewis R Roberts; Justin L Mott
Journal:  Hepatology       Date:  2011-12-19       Impact factor: 17.425

2.  Induction of cancer-related microRNA expression profiling using excretory-secretory products of Clonorchis sinensis.

Authors:  Jhang Ho Pak; In Ki Kim; Seon Min Kim; Sejung Maeng; Kyoung Ju Song; Byoung-Kuk Na; Tong-Soo Kim
Journal:  Parasitol Res       Date:  2014-09-14       Impact factor: 2.289

3.  Correlation between discharged worms and fecal egg counts in human clonorchiasis.

Authors:  Jae-Hwan Kim; Min-Ho Choi; Young Mee Bae; Jin-Kyoung Oh; Min Kyung Lim; Sung-Tae Hong
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

Review 4.  Current status and perspectives of Clonorchis sinensis and clonorchiasis: epidemiology, pathogenesis, omics, prevention and control.

Authors:  Ze-Li Tang; Yan Huang; Xin-Bing Yu
Journal:  Infect Dis Poverty       Date:  2016-07-06       Impact factor: 4.520

Review 5.  Clonorchis sinensis, an oriental liver fluke, as a human biological agent of cholangiocarcinoma: a brief review.

Authors:  Tong-Soo Kim; Jhang Ho Pak; Jong-Bo Kim; Young Yil Bahk
Journal:  BMB Rep       Date:  2016-11       Impact factor: 4.778

Review 6.  The role of helminths in the development of non-communicable diseases.

Authors:  Yifan Wu; Megan Duffey; Saira Elizabeth Alex; Charlie Suarez-Reyes; Eva H Clark; Jill E Weatherhead
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

7.  Structural Analysis of an Epitope Candidate of Triosephosphate Isomerase in Opisthorchis viverrini.

Authors:  Jonghyeon Son; Sulhee Kim; So Eun Kim; Haemin Lee; Myoung-Ro Lee; Kwang Yeon Hwang
Journal:  Sci Rep       Date:  2018-10-10       Impact factor: 4.379

8.  Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models.

Authors:  Safiah Ibrahim Althurwi; Jun Q Yu; Philip Beale; Fazlul Huq
Journal:  Int J Mol Sci       Date:  2020-10-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.